Literature DB >> 10558605

Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2000 rates. Department of Health and Human Services (HHS), Health Care Financing Administration (HCFA). Final rule.

.   

Abstract

We are revising the Medicare hospital inpatient prospective payment systems for operating costs and capital-related costs to implement changes arising from our continuing experience with the systems. In addition, in the addendum to this final rule, we describe changes in the amounts and factors necessary to determine rates for Medicare hospital inpatient services for operating costs and capital-related costs. These changes are applicable to discharges occurring on or after October 1, 1999. We also set forth rate-of-increase limits as well as policy changes for hospitals and hospital units excluded from the prospective payment systems. Finally, we are revising certain policies governing payment to hospitals for the direct costs of graduate medical education.

Entities:  

Mesh:

Year:  1999        PMID: 10558605

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  4 in total

1.  Impact of the Medicare Short Stay Transfer Policy on patients undergoing major orthopedic surgery.

Authors:  John D FitzGerald; W John Boscardin; Bevra H Hahn; Susan L Ettner
Journal:  Health Serv Res       Date:  2007-02       Impact factor: 3.402

2.  Hospital, employment, and price indicators for the health care industry: second quarter 1999.

Authors:  M L Seifert; S K Heffler; C S Donham
Journal:  Health Care Financ Rev       Date:  1999

3.  Hospital, employment, and price indicators for the health care industry: third quarter 1999.

Authors:  S Martin; M L Seifert; M Zezza
Journal:  Health Care Financ Rev       Date:  2000

4.  Is case-mix adjustment necessary for an expanded dialysis bundle?

Authors:  Richard A Hirth; Robert A Wolfe; John R Wheeler; Erik C Roys; Philip J Tedeschi; Alyssa S Pozniak; Glenn T Wright
Journal:  Health Care Financ Rev       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.